Presentation Outline ICHP Annual Meeting September 13-15
Presentation Outline ICHP Annual Meeting September 13-15
Presentation Outline ICHP Annual Meeting September 13-15
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
IV Acetaminophen –Average Length of<br />
Stay and Charges<br />
May 2012, ICD‐9 Code 7<strong>15</strong>.36<br />
(When IV APAP was used)<br />
May 2011, ICD‐9 Code<br />
7<strong>15</strong>.36(When IV APAP was NOT<br />
used)<br />
May 2012, ICD‐9 Code<br />
7<strong>15</strong>.35(When IV APAP was used)<br />
May 2011, ICD‐9 Code<br />
7<strong>15</strong>.35(When IV APAP was NOT<br />
used)<br />
May 2012, ICD‐9 Code 654.21<br />
(When IV APAP was used)<br />
May 2011, ICD‐9 Code 654.21<br />
(When IV APAP was NOT used)<br />
Average Length of Stay Average Charges<br />
2.68 days $36,100<br />
2.88 days $35,600<br />
2.56 days $42,600<br />
3 days $42,500<br />
2.56 days $7,700<br />
2.4 days $7,600<br />
Review<br />
• What positives do you see from IV<br />
Acetaminophen use?<br />
• What negatives do you see from IV<br />
Acetaminophen use?<br />
• What additional research data would you like<br />
to see about IV Acetaminophen use?<br />
Assessment Question<br />
Which of the following statements is/are true regarding<br />
the infusion of intravenous acetaminophen?<br />
A. Infusion time is 30 minutes<br />
B. Cmax occurs at 30 minutes<br />
C. Overall AUC is similar to oral administration<br />
D. After penetration of the seal the product should be<br />
used within 12 hour<br />
E. All of the above<br />
IV Acetaminophen – Multiple<br />
Dosing<br />
• <strong>15</strong> patients who<br />
received multiple<br />
doses of IV APAP<br />
(average of 3.23<br />
doses) were randomly<br />
selected and<br />
compared to <strong>15</strong><br />
patients who received<br />
a single dose of IV<br />
APAP.<br />
Total oral<br />
morphine<br />
equivalent<br />
dose<br />
Multiple<br />
doses of IV<br />
APAP<br />
Single dose<br />
of IV APAP<br />
Calculated<br />
p-value<br />
27.93mg 26.47mg 0.8946<br />
Symptoms of 6 patients, 5 patients, 1.0 (Fisher’s<br />
nausea/vomiti receiving g total receiving g total exact test) )<br />
ng 0-24 hours of 10 doses of of 8 doses of<br />
after surgery ondansetron ondansetron<br />
4mg<br />
4mg<br />
Average<br />
lowest oxygen<br />
saturation 0-<br />
24 hours after<br />
surgery<br />
Average<br />
lowest<br />
respiratory<br />
rate 0-24<br />
hours after<br />
surgery<br />
Conclusion<br />
94.2% 94.83%<br />
16.2 16.08<br />
• Place in therapy is undetermined<br />
– Results of our DUE failed to demonstrate that clinical<br />
advantages outweigh the economic burden<br />
• Additional research needed<br />
– Larger sample size<br />
– Time to first physical therapy<br />
– Frequency of nausea and vomiting<br />
• Needs to be proven fiscally responsible<br />
– Anticipated benefits must be observed<br />
Questions<br />
8/29/2012<br />
3